TLR9 and systemic lupus erythematosus: In one initial study with the lupus model induced by anti-DNA BCR transgene and homozygous deficiency of the inhibitory receptor FcγIIB, lack of Tlr9 was found to block class switching of autoreactive B cells to the pathogenic IgG2a and 2b subclasses with reduced pathology and mortality [16].